Term 2 Pharm - Epilepsy Drugs Flashcards

1
Q

Key Drugs for Epilepsy:

A
Phenobarbital
   Phenytoin
   Ethosuximide
   Benzodiazepines (lorazepam, etc.)
   Carbamazepine
   Valproate
   Gabapentin
   Lamotrigine
   Topiramate
   Levetiracetam
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What Are Epileptic Seizures ?

A

“Occasional, sudden, excessive, rapid and local discharges of gray matter”

  • Seizures require repetitive and synchronized firing of neurons.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How Do Neurons Work ?

A

The resting membrane potential of a neuron depends as first approximation the K+ conductance and is ~ -70mv.

Each neuron has many ion channels for K+, Na+, Ca++, Cl- and other ions.

Ion channels may be voltage-gated, or ligand-gated.

Opening of Ca++ and Na+ channels tends to produce depolarization.

Opening of K+ and Cl- channels tends to produce hyperpolarization.

Neurotransmitters released from presynaptic neurons act on the ligand-gated channels of postsynaptic neurons.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe Seizures at the Neuronal Level

A
  • Excitatory synapses generate EPSPs by depolarization making action potentials more likely.
  • Inhibitory synapses generate IPSPs by hyperpolarization, making action potentials less likely.
  • If excitation substantially exceeds inhibition, repetitive action potentials result in seizures.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Tell me about GABA

A

GABA (gamma-amino butyric acid) Mediates Inhibition

  • GABA binding to its receptor opens a chloride channel that hyperpolarizes the cell. This makes neuronal firing and seizures less likely.
  • Some anti-epileptic drugs, benzodiazepines and barbiturates, are agonists at GABA receptors.
  • Different receptor sub-types may mediate different functions.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Tell me about Glutamate

A

Glutamate Mediates Excitation

  • Glutamate binding to its receptors opens Na+ and Ca++ channels that depolarize the cell, making neuronal firing and seizures more likely.
  • Some anti-epileptic drugs block release of glutamate (lamotrigine), or are glutamate receptor antagonists (topiramate).
  • There are many glutamate receptor sub-types.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Classification of Epilepsy and Seizures:

A

2 types: Generalized or Partial

General seizures
- initially bilateral
- widespread cerebral involvement
“In generalized epilepsy the whole brain is electrically irritable and generalized seizures involve the whole brain at onset.”

Partial seizure
- Focal/Localization related
“In focal epilepsy, one part of the brain is electrically irritable, and partial seizures begin from there and may spread diffusely (secondary generalization).”

Most drugs work for both types of seizures, but some are better for one kind and some for another. The reasons are unclear, and the facts are not explained by the apparent mechanisms of the drugs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Mechanisms of Anti-epileptic Drugs

A

ALL anti-epileptic drugs are for treatment only. They do NOT cure epilepsy or prevent a seizure from occurring

  • Block Na-dependent APs - this will decrease sustained high frequency neuronal firing.
    (Drugs acting on Na+ channels include phenytoin, carbamazepine, valproate, topiramate and lamotrigine)
  • Calcium channel blockade = Reduce Ca uptake
    (Ethosuximide blocks T-type Ca++ channels.
    These are found in the thalamus… Good for petit mal seizures/Absence seizures)
  • GABA agonists = GABA binding to its receptor opens a chloride channel, entry of chloride hyperpolarizes the neuron and makes firing action potentials less likely.
    (Barbiturates, benzodiazepines and topiramate are GABA agonists… Barbituates prolong the GABA-mediated Cl- channel openings, decreasing CNS excitability… Benzodiazepines increase the frequencey of GABA-mediated Cl- channel openings, decreasing CNS excitability)
  • Glutamate antagonists = Glutamate binding opens a Na+ and Ca++ channel.
    Entry of Na+ and Ca++ depolarizes the neuron, and makes firing of action potentials more likely –> BLOCK this (Lamotrigine blocks glutamate release, Topiramate is a glutamate antagonist)

*Lamotrigine is an anti-epileptic via more than one mechanism (black Na channels AND blocks glutamate release)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Describe a petit mal/absence seizure

A

Absence (petit mal) seizures have a 3 Hz spike wave discharge which probably involves a cortico-thalamic loop.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Pharmacokinetic Principles: Absorption

A

“entry of drug into the blood”

  • Timing varies widely by drug, formulation,patient characteristics
  • Essentially complete for all AEDs (except gabapentin which has a saturable intestinal transporter at high doses)
  • Generally slowed by food in stomach (CBZ may be exception)
  • Usually takes several hours (important for rapid control of seizures, and for interpreting blood levels)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Steady State and Half-Life

A
  • It takes 5 half-lives to reach steady state.
  • With a particular dose one wants the steady state level to be in the therapeutic range.
  • It the drug has a long half life, one needs a loading dose to reach the therapeutic range rapidly.

IMPORTANT for phenytoin and phenobarbital.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Therapeutic Index

A

T.I. = TD 5O% / ED 50%

One wants the ED50%, which is the dose or blood level at which 50% of users benefit, to be as low as possible; and the TD50%, which is the dose or blood levels at which 50% of users have toxic side-effects, to be as high as possible.

Most anti-epileptic drugs have fairly good therapeutic indices, but comparisons between drugs are difficult because of limited data and individual differences.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Pharmacokinetic Principles: Elimination

A

Elimination: removal of active drug from the blood by metabolism and excretion.

  • Metabolism/biotransformation — generally hepatic; usually rate-limiting step.
  • Excretion — mostly renal (active and inactive metabolites)
  • Changes in metabolism over time (auto-induction with carbamazepine) or with polytherapy (enzyme induction or inhibition).
  • Differences in individual metabolism.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

The Cytochrome P-450 Isozyme System

The principle enzymes involved with AED metabolism include

A

CYP2C9, CYP2C19, CYP3A4

  • The enzymes most involved with drug metabolism. Found in the liver.
  • Nomenclature based upon homology of amino acid sequences.
  • Enzymes have broad substrate specificity, and individual drugs may be substrates for several enzymes.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

The Cytochrome P-450 Isozyme System

Inducers:

A
  • phenobarbital
  • ethosuximide
  • phenytoin
  • carbamazepine
  • tobacco/cigarettes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

The Cytochrome P-450 Isozyme System

Inhibitors:

A
  • erythromycin
  • Ca++ channel blockers
  • trimethoprim/sulfa
  • fluconazole
  • valproate
17
Q

Drug Metabolizing Enzymes: UDP-Glucuronyltransferase(UGT)

A

Important pathway for drug metabolism/inactivation, found in the liver. Currently less well described than the CYP-450 system.

Several isozymes that are involved in AED metabolism include: UGT1A9 (valproate), UGT2B7 (valproate, lorazepam), UGT1A4 (lamotrigine).

GLUCORONIDATION is followed by renal excretion.

18
Q

AED Metabolizing Enzymes and Specific Inhibitors:

A

Phenytoin (CYP2C9, CYP2C19)
Inhibitors: valproate, fluoxetine, topiramate, fluconazole
Carbamazepine (CYP3A4, CYP2C8, CYP1A2)
Inhibitors: ketoconazole, fluconazole, erythromycin, diltiazem
Lamotrigine (UGT 1A4)
Inhibitor: valproate

*keep in mind that levetiracetam does not induce or inhibit, and is not much subject to metabolism.

19
Q

Pharmacokinetic Factors in the Elderly

A
  • Absorption: little change.
  • Distribution: decrease in lean body mass important for highly lipid-soluble drugs.
    fall in albumin leading to higher free fraction.
  • Metabolism: slowed because of decreased hepatic enzyme content/slowed because of decreased blood flow.
  • Excretion: decreased renal clearance.
Elderly = lower doses
Babies = lower doses
Children = higher doses
20
Q

Pharmacokinetic Factors in Pediatrics

A

Neonates often need lower per kg doses.

  • Low protein binding.
  • Low metabolic rate.

Children often need higher per kg doses.
- Faster metabolism.

Elderly = lower doses
Babies = lower doses
Children = higher doses
21
Q

Pharmacokinetic Factors in Pregnancy

A
  • Increased volume of distribution because of hemodilution.
  • Lower serum albumin leads to lower protein-bound drug levels, but free drug levels may be unchanged.
  • Faster hepatic metabolism.
  • Higher doses of AEDs are sometimes needed, but probably less than predicted by measured total (protein-bound + free) levels. It is helpful to measure free levels. Consider more frequent dosing.
  • Lamotrigine levels, particularly, tend to fall, and it is the favored drug in pregnancy because of few birth defects.
22
Q

AEDs and Pharmacodynamic Interactions

A

Valproate and Lamotrigine may really be SYNERGISTIC.

23
Q

Summary of AED Metabolism

A
  • Most anti-epileptic drugs are metabolized by the hepatic microsomal cytochrome P-450 system.
  • Then they are conjugated to form glucoronides that are renally excreted.
  • Older AEDs tend to be enzyme inducers, particularly phenobarbital , phenytoin and carbamazepine. Newer drugs are less likely to induce metabolic enzymes.
  • Doses of birth control pills, coumadin, anti-depressants, and cholesterol-lowering drugs need to be adjusted, and cancer chemotherapy may be less effective, in the presence of enzyme- inducing AEDs.
  • Enzyme inhibition can be an important factor: Ca++ channel blockers and macrolide antibiotics raise levels of carbamazepine; valproate raises levels of lamotrigine.
24
Q

Side-effects of Anti-epileptic Drugs: Systemic Problems

A

Allergic reactions:
rash is common (1-5%).
mucositis, hepatitis, bone marrow suppression are fortunately rare (

25
Q

Side-effects of Anti-epileptic Drugs: CNS Effects

A

All tend to be CNS depressants and somewhat sedating. Phenytoin and Lamotrigine are exceptions.

Fatigue is common.

Headaches, blurred vision, double vision and imbalance are also common.

Mild confusion is common, psychosis is rare.

26
Q

Side-effects of Anti-epileptic Drugs: Weight Changes

A

Weight neutral: phenytoin, lamotrigine, levetiracetam.

Weight gain: carbamazepine, gabapentin, valproate.

Weight loss: topiramate.

27
Q

Side-effects of Anti-epileptic Drugs: Endocrine Problems

A
  • PCOS/Hyperandrogenism may occur in women in relation to AED (because of VPA & CBZ)
  • Bone metabolism: Phenobarbital phenytoin and carbamazepine have been implicated in osteoporosis. The mechanisms are complex and include malabsorption of vitamin D, Stimulation of PTH action, and stimulation of osteoclast activity - Patients on these drugs should in middle age get bone scans, receive calcium and vitamin D supplementation, and maybe drugs like alendronate.
28
Q

Side-effects of Anti-epileptic Drugs: Birth Defects

A

The natural rate of birth defects is 2-3%. This is probably doubled by anti-epileptic drugs.

  • Carbamazepine may be safer than phenytoin and phenobarbital.
  • Lamotrigine and levetiracetam seem to have a low rate of birth defects; topiramate may cause cleft palate defects.
  • Valproate is definitely bad, produces neural tube defects and learning disabilities.
  • Pregnancy multivitamins and 3mg of folate daily may reduce the risk of neural tube defects. With enzyme inducing drugs, give Vitamin K 10mg daily by mouth in the last 6 weeks, to reduce hemorrhages in the neonates.

Neural tube defects are mainly associated with VPS & CBZ

29
Q

Phenobarbital

A

Use: Effective for all seizure types except absence. Can be given PO or IV. IV form very useful in status epilepticus.

Mechanism: GABA agonist. Opens chloride channel. Produces hyper polarization.

Metabolism: Long half life (100 hours). Can be given PO or IV. Needs to be loaded. Hepatic metabolism. Hepatic enzyme inducer.

Toxicity: Hyperactivity in children. Sedation in adults. Joint and connective tissue problems.

30
Q

Phenytoin

A

Use: Effective against all seizure types except absence. Better for focal and secondarily generalized seizures than for primary generalized ones.

Mechanism: Blocks voltage-gated Na+ channels.

Metabolism: Can be given PO or IV. Poorly absorbed PO in children. Has zero-order kinetics at high doses because of enzyme saturation. Hepatic metabolism. Variable half- life (6-24 hours). Hepatic enzyme inducer.

Toxicity: Gingival hyperplasia, osteomalacia, ataxia. Need to supplement calcium, vitamin D, vitamin K, and folate.

31
Q

Benzodiazepinesdiazepam, lorazepam, etc.

A

Use: Very effective against all seizure types. Tolerance develops rapidly (months), so bad for chronic therapy. Drugs of choice for status epilepticus, alcohol withdrawal symptoms and alcohol withdrawal seizures. Good sedatives and anxiolytics.

Mechanism: Agonists at the GABA receptor.

Metabolism: PO or IV administration. Hepatic metabolism, but not major enzyme inducers.

Toxicity: Sedation, depression, withdrawal seizures.

*Good for acute therapy NOT good for long term b/c withdrawal causes a seizure

32
Q

Carbamazepine

A

Use: Excellent for focal and secondarily generalized seizures. Less effective for primary generalized seizures. Also a mood stabilizer for bipolar disorder. Works for neuropathic pain and trigeminal neuralgia.

Mechanism: Na+ channel blockade.

Metabolism: Only has oral preparation. ½ life 12 hours. Hepatic metabolism. Hepatic enzyme inducer. Levels increased by Calcium channel blockers, and macrolide antibiotics.

Toxicity: Blurred vision, sedation, neutropenia, hyponatremia, weight gain.

*GOOD 1st line drug (for focal and secondarily generalized seizures)
BEST drug for focal seizures 
ONLY given by mouth 
Toxicity is usually only at high doses 
Good for chronic painful conditions
33
Q

Ethosuximide

A

Use: only for absence seizures

Mechanism: Blocks T-type Calcium Channels

Metabolism: Only oral preparation. Has good GI absorption. ½ life 24-48 hours. Mild hepatic enzyme inducer. Hepatic metabolism

Toxicity: Sedation, GI distress, occasional behavioral changes.

34
Q

Valproate

A

Use: Very wide spectrum of efficacy. Works for all seizure types. Also used for migraine and bipolar disorder.

Mechanism: Not well understood. May block Na+ channels. Probably also affects GABA levels, Ca++, and K+ conductances.

Metabolism: Oral and IV preparation. Half Life ~15 hours. Hepatic metabolism. Not a major enzyme inducer.

Toxicity: GI upset, weight gain, menstrual problems, hair loss, low platelet count, pancreatitis, hepatic encephalopathy sometimes but not always associated with elevated ammonia levels and carnitine deficiency.

35
Q

Gabapentin

A

Use: effective against partial and secondarily generalized seizures. Not good for primary generalized seizures. Also a good anxiolytic, sedative, and anti-spasmodic. Works well for peripheral neuropathy and other painful states.

Mechanism: Increases GABA levels in the brain. May have other mechanisms of action including blockade of Ca++ channels.

Metabolism: PO preparation only. Short ½ life (6 hours). Well absorbed, except at very high doses. Not metabolized and excreted in the urine. Few drug interaction. Not an enzyme inducer.

Toxicity: sedation, particularly in the elderly. Occasional GI distress, and pedal edema.

36
Q

Lamotrigine

A

Use: Broad spectrum efficacy against all seizure types. Also works for bi-polar disorder, and neuropathic pain.

Mechanism: Probably blocks release of glutamate pre-synaptically and blocks Na+ channels post-synaptically.

Metabolism: Only an oral preparation Renally excreted after hepatic glucoronidation. Not a major enzyme inducer. ½ life of 24 hours.

Toxicity: Allergic rash 5-10%. Other problems minor. Not sedating. May cause insomnia.

37
Q

Topiramate

A

Use: Broad spectrum of efficacy, but not particularly good for absence. Good for migraine prevention. Some use in neuropathic pain. Causes weight loss.

Mechanism: Multiple mechanisms. Na+ channel blockade, GABA agonist, glutamate antagonist.

Metabolism: Some hepatic metabolism, but mainly renal clearance without change. ½ life of 24 hours. Only an oral preparation. Not a hepatic enzyme inducer.

Toxicity: Sedation, aphasia, parasthesias, kidney stones.

38
Q

Levetiracetam

A

Use: Broad spectrum of use for focal and generalized seizures. Equivalent IV or PO dosing. Favorite anti-epileptic drug in hospitals.

Mechanism: Controversial, blocks Ca++ channels, interferes with action of SV2 protein which is necessary for exocytosis of neuro-transmitter vesicles.

Metabolism: 2/3 excreted renally unchanged. Some enzymatic hydrolysis by liver and RBCs to inactive metabolites. Not protein-bound. Not an enzyme inducer.

Toxicity: Cognitive and behavioral problems.

39
Q

Medical therapy of epilepsy: Conclusions

A
  • Generalized epilepsy is easier to control than focal epilepsy, unless there is diffuse brain disease.
  • Valproate is the most effective drug.
  • Lamotrigine and levetiracetam are best for child-bearing women.
  • 80-90% of patients do well.
  • Focal epilepsy is more common than generalized epilepsy (70:30), and treatment is less effective.
  • Carbamazepine is probably the best drug.
  • Lamotrigine and levetiracetam are other good choices.
  • 50% of patients with focal epilepsy respond well to the first drug, and another 20% to subsequent drug trials and combination therapy.
  • New drugs show efficacy similar to old drugs, but may be more effective for some people, and vice versa.
  • If 2-3 drugs fail, each new drug has